Yaldigo

Yaldigo (Mesalazine) is an oral medication used for gastrointestinal conditions like ulcerative colitis. It belongs to the aminosalicylate class and works locally in the colon to reduce inflammation. This EU-manufactured option is suitable for adults and children.

Mesalazine is commonly prescribed to treat mild to moderate ulcerative colitis, helping to reduce symptoms such as abdominal pain and diarrhea. It may also be used for maintenance of remission in ulcerative colitis. Some healthcare providers may consider it for Crohn’s disease involving the colon, though this is less common.

Users often report reduced urgency and frequency of bowel movements after starting Mesalazine. Some may notice less abdominal discomfort and improved stool consistency. Effects can take several weeks to become fully noticeable as the medication works locally in the digestive tract.

Store Yaldigo at room temperature away from moisture and heat. Keep out of reach of children and pets. If you experience worsening symptoms or signs of an allergic reaction, such as rash or swelling, contact a healthcare provider promptly. Do not crush or chew extended-release tablets.

Mesalazine may interact with other drugs that affect kidney function, such as certain diuretics or NSAIDs. Blood thinners like warfarin may have altered effects when taken with Mesalazine. Always inform your healthcare provider about all medications and supplements you are using before starting treatment.